Respiratory Health news

MERMAIDS ARI – NICRN supported sites feature

 News, Respiratory Health  Comments Off on MERMAIDS ARI – NICRN supported sites feature
Mar 282017
 
MERMAIDS ARI - NICRN supported sites feature

Tweet MERMAIDS – Multi-centre EuRopean study of MAjor Infectious Disease Syndromes Meet the Northern Ireland teams in Craigavon and Altnagelvin Congratulations at the continued competitive delivery of this study by these 2 NI centres. We thank the Investigators Dr(s) Convery, Kelly and Lockhart and not forgetting the dedicated NICRN staff and site support staff of […]

Vertex VX11-770-110 study

 All News, Interest Groups, News, Respiratory Health  Comments Off on Vertex VX11-770-110 study
Sep 262013
 

A Phase 3, Randomized, Double-blind, Placebo Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects with Cystic Fibrosis who have the R117H-CFTR Mutation. Our Belfast site was the highest global recruiter with a recruitment rate of 217% (target: 6; randomised 13).  All patients have rolled over to the VX11-770-112 study.

Respicopea Cough study

 News  Comments Off on Respicopea Cough study
Sep 262013
 

This multicentre, double-blind, placebo-controlled, pivotal study was the first study in the persistent cough population that was adopted by the NICRN (Respiratory Health). Recruitment to this study was extremely successful with the overall recruitment target being met within the 12-month timeframe. Local recruitment was equally successful; the NICRN (Respiratory Health) were the fourth highest recruiters, […]

© 2019 NICRN - Terms & Conditions Supported by the HSC R&D Division, Public Health Agency.